OSSIRENE
Dead / Cancelled — Cancelled — Section 8 (as of 20 Jul 2002)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74252178
- Registration number
- 1914059
- Mark type
- Word mark
- Filed
- 05 Mar 1992
- Published for opposition
- 29 Sept 1992
- Registered
- 22 Aug 1995
- Attorney of record
- Martin W. Schiffmiller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation used as adjunct to cancer chemotherapy
Owner
- BAKER NORTON PHARMACEUTICALS, INC., Miami, FL, US
- BAKER NORTON PHARMACEUTICALS, INC., Miami, FL, US
- Baker Cummins Pharmaceuticals, Inc., Miami, FL, US
- Baker Cummins Pharmaceuticals, Inc., Miami, FL, US
Prosecution history
- 20 Jul 2002 — CANCELLED SEC. 8 (6-YR)
- 22 Aug 1995 — REGISTERED-PRINCIPAL REGISTER
- 20 Apr 1995 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Apr 1995 — ASSIGNED TO EXAMINER
- 14 Apr 1995 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Mar 1995 — USE AMENDMENT FILED
- 24 Oct 1994 — SOU EXTENSION 3 GRANTED
- 13 Sept 1994 — SOU EXTENSION 3 FILED
- 29 Apr 1994 — SOU EXTENSION 2 GRANTED
- 10 Mar 1994 — SOU EXTENSION 2 FILED
- 02 Nov 1993 — SOU EXTENSION 1 GRANTED
- 08 Sept 1993 — SOU EXTENSION 1 FILED
- 23 Mar 1993 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 29 Sept 1992 — PUBLISHED FOR OPPOSITION
- 28 Aug 1992 — NOTICE OF PUBLICATION